| Name | Title | Contact Details |
|---|
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
InterMune, Inc. (InterMune) is a biotech company focused on developing and commercializing therapies in pulmonology and hepatology.
The Y makes accessible the support and opportunities that empower people and communities to learn, grow and thrive.
LUZ is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Soap Transcription is a Wayland, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.